FDA
- Status: approved
Sequential therapy for 10 days (Sequential therapy for 10 days) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.